In addition, trastuzumab has been shown to induce the overexpression of HER2 in HER2‐positive small cell lung cancer (SCLC) cells through the down‐regulation of both miR‐125b and miR‐125a.153. This evidence concerns the gene ERBB2 and small cell lung carcinoma.